John Lepore, who was in charge of policy and advocacy at Mastercard, has joined Moderna, the biotechnology company that signed a $1.5B deal to sell 100M doses of its COVID-19 vaccine to the US government as part of the Operation Warp Speed effort.
As senior VP-government engagement, Lepore reports to CEO Stéphane Bancel.
At Mastercard, Lepore led a team of 80 staffers in charge of global public policy, regulatory affairs and litigation. Earlier, he was head of global government affairs at RELX (ReedElsevier LexisNexis) Group and VP-government affairs for GlaxoSmithKline's emerging markets unit.
Bancel said Lepore's "experience in developing corporate strategy for vaccines at GSK along with his unique blend of government affairs, public policy, commercial and legal experience" will be an important asset as Moderna transitions into a global commercial-stage enterprise.